Rapid Reads News

HOMEcorporatetechentertainmentresearchmiscwellnessathletics

Roth MKM Sticks to Their Buy Rating for BioRestorative Therapies (BRTX)


Roth MKM Sticks to Their Buy Rating for BioRestorative Therapies (BRTX)

Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter

Aschoff covers the Healthcare sector, focusing on stocks such as GeoVax Labs, Nuwellis, and Tenax Therapeutics. According to TipRanks, Aschoff has an average return of -17.7% and a 29.93% success rate on recommended stocks.

Currently, the analyst consensus on BioRestorative Therapies is a Moderate Buy with an average price target of $8.00.

The company has a one-year high of $2.55 and a one-year low of $1.03. Currently, BioRestorative Therapies has an average volume of 362.3K.

Previous articleNext article

POPULAR CATEGORY

corporate

4431

tech

3917

entertainment

5534

research

2602

misc

5621

wellness

4525

athletics

5652